It is classified by the Food and Drug Administration (FDA) as a dietary supplement when it is sold in oral forms, such as capsules, liquids, or liposomal delivery systems
BioLegend), and rhIL-33 (100 ng/ml
This can increase the severity of illness and contribute to additional conditions arising
Cannot redeclare control with same name "grid_1_qv_name_typography_typography"
doi: 10.3389/fendo.2026.1709556 Received 23 September 2025 Revised 15 January 2026 Accepted 26 January 2026 Published 11 February 2026 Volume 17 - 2026 Edited by Abdel Halim Harrath, King Saud University, Saudi Arabia Reviewed by Aldo Ferreira-Hermosillo, Mexican Social Security Institute, Mexico Raquel Evelyn Horowitz, Montefiore Medical Center, United States Updates Copyright 2026 Wang, Chen, Wang, Song and Zhang